Beam Therapeutics BEAM
NASDAQ BEAM
$24.50 +0.11 (+0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Beam Therapeutics (BEAM) recorded Return on Capital Employed [ROCE] of -27.95% in Q2 2026, up 7.59 percentage points from -35.54% a year earlier but down 1.52 percentage points from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Beam Therapeutics reported Return on Capital Employed [ROCE] of -32.09%, up 5.70 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of +33.78 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -37.79% in FY2024 (-23.02 pp), -14.77% in FY2023 (+13.81 pp), -28.58% in FY2022 (+23.78 pp) and -52.35% in FY2021 (+13.51 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -43.49% in Q4 2024 to -14.86% in Q1 2024 over the past five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased for three consecutive quarters, with an average year-over-year change of -5.18 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 43.25 percentage points in Q1 2022, against a drop of 28.40 percentage points in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -26.42% (Q1 2026), -29.53% (Q4 2025) and -39.90% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Beam Therapeutics 2.52 Bn 2.52 Bn - -27.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -27.95%
Mar 31, 2026 -26.42%
Dec 31, 2025 -29.53%
Sep 30, 2025 -39.90%
Jun 30, 2025 -35.54%
Mar 31, 2025 -37.66%
Dec 31, 2024 -43.49%
Sep 30, 2024 -17.40%
Jun 30, 2024 -16.28%
Mar 31, 2024 -14.86%
Dec 31, 2023 -15.09%
Sep 30, 2023 -36.15%
Jun 30, 2023 -33.64%
Mar 31, 2023 -32.33%
Dec 31, 2022 -30.16%
Sep 30, 2022 -27.32%
Jun 30, 2022 -23.81%
Mar 31, 2022 -21.55%
Dec 31, 2021 -35.61%
Sep 30, 2021 -40.04%
API Access

Beam Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BEAM&period=max&api_key=YOUR_API_KEY